The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands

There are over 385,000 cases of atrial fibrillation (AF) in the Netherlands, with over 45,000 new cases each year. Among other things, AF patients are at high risk of stroke. Patients are often prescribed oral anticoagulation, such as vitamin K antagonists (VKA), to mitigate these risks. A recently introduced class of oral anticoagulants, non-vitamin K antagonists (NOAC), is quickly gaining currency in global clinical practice. This study provides insight into the changes these new drugs will bring about in Dutch clinical practice.